Heart valve surgery in China: yesterday and today.
The past 20 years have seen rapid development in heart valve surgery in China. By the late 1990s, there were 6000 heart valve operations performed each year. Statistical analysis has shown that rheumatic heart disease is still the leading cause of valvular damage leading to surgery, as it had been 40 years before. The progressive fibrosis, sclerosis and calcification of the mitral valve that characterises rheumatic heart disease caused high mortality for all forms of mitral valve surgery in China in the 1960s. At that time, the introduction of closed mitral commissurotomy, initially highly effective in alleviating symptoms, was later found to result in re-stenosis in a significant cohort of patients. This was progressively replaced with open mitral commissurotomy. Today, mitral valve replacement represents 60-70% of valvular replacement procedures, followed by double-valve (mitral and aortic) replacement (20-25%). It has been shown both in China and elsewhere that careful selection of patients for an absence of mitral calcification leads to higher success rates for surgery. Heart valve replacement surgery in China now attains international standards in terms of the numbers of cases and surgical outcomes. Further long-term data collection and analysis are essential to aid the further development of the field.